{"id":111463,"date":"2026-11-04T12:04:07","date_gmt":"2026-11-04T12:04:07","guid":{"rendered":"https:\/\/www.europesays.com\/spain\/111463\/"},"modified":"2026-11-04T12:04:07","modified_gmt":"2026-11-04T12:04:07","slug":"stereo-seq-now-available-in-madrid-via-mgi-tech-partnership","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/spain\/111463\/","title":{"rendered":"Stereo-seq now available in madrid via MGI tech partnership"},"content":{"rendered":"<p>Madrid, Spain, November 4, 2026\u00a0 &#8211;  MGI Tech Co., Ltd. (\u201cMGI\u201d), a company committed to developing core tools and technologies that drive innovation in life sciences, today announced the Genomics Unit at the Madrid Science Park (Parque Cient\u00edfico de Madrid, PCM) has become the first STOmics Certified Service Provider (CSP) in Madrid and the second at the national level in Spain. This collaboration brings Stereo-seq spatial transcriptomics capabilities to the Spanish R&amp;D ecosystem, offering researchers, hospitals, and deep-tech companies access to unbiased, whole-transcriptome spatial analysis at true cellular and subcellular resolution.<\/p>\n<p><img decoding=\"async\" class=\"rounded-img\" src=\"https:\/\/www.europesays.com\/spain\/wp-content\/uploads\/2026\/11\/ImageForNews_850561_17937923620161042.jpg\"   width=\"800\" height=\"533px\" role=\"presentation\" style=\"display: block; margin-left: auto; margin-right: auto;\"\/><\/p>\n<p style=\"text-align: right;\">Image Credit: MGI<\/p>\n<p>Through this new certification, PCM will offer Stereo-seq (Spatial Enhanced Resolution Omics-sequencing) based on DNBSEQ technology, enabling unbiased, whole-transcriptome spatial analysis at true cellular and subcellular resolution(500 nm). By mapping gene expression while preserving tissue context, the platform overcomes a key limitation of traditional genomics and is expected to accelerate advances in precision oncology, neuroscience, embryology, and plant biology.<\/p>\n<p>To ensure robustness and reproducibility, the new service is delivered through an end-to-end collaboration with the Histology and Microscopy Services of the National Center for Biotechnology (CNB-CSIC). This integrated workflow spans tissue processing and imaging through to sequencing and bioinformatic analysis, providing a complete solution for research groups, health research institutes, and the pharma\/biotech industry.<\/p>\n<p>\u201cWe are pleased to welcome Parque Cient\u00edfico de Madrid as the first STOmics Certified Service Provider in the Community of Madrid,\u201d said Fang Chen, Vice President of MGI and General Manager of Europe &amp; Africa at MGI. \u201cThis partnership reflects our shared commitment to expanding access to high-resolution spatial transcriptomics across Europe. By combining MGI\u2019s Stereo-seq technology with PCM\u2019s genomic expertise and CNB-CSIC\u2019s histology capabilities, we are creating a robust local hub that will empower Spanish researchers to explore biology at unprecedented resolution.\u201d<\/p>\n<p>\u201cBecoming the first STOmics Certified Service Provider in the Community of Madrid is a major milestone for our facility,\u201d said Mar\u00eda Jos\u00e9 L\u00f3pez,Head of the Genomics Unit\u00a0of \u00a0PCM. \u201cThanks to this certification and our comprehensive alliance with the Histology and Microscopy services at CNB-CSIC, we can now offer the R&amp;D ecosystem an end-to-end spatial transcriptomics solution. Stereo-seq enables our researchers and biotech partners to map the whole transcriptome at nanoscale resolution, pushing the boundaries of neuroscience, oncology, and developmental biology like never before.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Madrid, Spain, November 4, 2026\u00a0 &#8211; MGI Tech Co., Ltd. (\u201cMGI\u201d), a company committed to developing core tools&hellip;\n","protected":false},"author":2,"featured_media":111464,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[37941,37942,82,37943,22018,37944,858,3043,37945],"class_list":["post-111463","post","type-post","status-publish","format-standard","has-post-thumbnail","category-madrid","tag-genomics","tag-histology","tag-madrid","tag-microscopy","tag-neuroscience","tag-oncology","tag-research","tag-technology","tag-transcriptomics"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/posts\/111463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/comments?post=111463"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/posts\/111463\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/media\/111464"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/media?parent=111463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/categories?post=111463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/spain\/wp-json\/wp\/v2\/tags?post=111463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}